MENU
+Compare
GHRS
Stock ticker: NASDAQ
AS OF
Mar 3 closing price
Price
$9.21
Change
-$0.92 (-9.08%)
Capitalization
568.18M

GHRS GH Research PLC Forecast, Technical & Fundamental Analysis

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders... Show more

GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GHRS with price predictions
Mar 03, 2025

GHRS's RSI Indicator descending into oversold zone

The RSI Oscillator for GHRS moved into overbought territory on March 03, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for GHRS moved above the 200-day moving average on February 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GHRS advanced for three days, in of 191 cases, the price rose further within the following month. The odds of a continued upward trend are .

GHRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 158 cases where GHRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GHRS as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GHRS turned negative on February 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

GHRS moved below its 50-day moving average on February 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GHRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GHRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.511) is normal, around the industry mean (11.712). P/E Ratio (0.000) is within average values for comparable stocks, (82.754). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.798). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (240.086).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GHRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GHRS is expected to report earnings to rise 25.88% to -21 cents per share on May 14

GH Research PLC GHRS Stock Earnings Reports
Q1'25
Est.
$-0.21
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.08
The last earnings report on February 27 showed earnings per share of -17 cents, beating the estimate of -22 cents. With 610.69K shares outstanding, the current market capitalization sits at 568.18M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGIAX34.43N/A
N/A
Putnam Focused Equity A
PQIAX40.80N/A
N/A
Principal Equity Income A
RWCEX10.96N/A
N/A
Redwheel Global Emerging Equity Ins
GSAFX23.01N/A
N/A
Goldman Sachs China Equity R6
OCLVX19.09-0.16
-0.83%
Optimum Large Cap Value C

GHRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-9.58%
MDGL - GHRS
43%
Loosely correlated
-8.15%
IVVD - GHRS
38%
Loosely correlated
-19.03%
IBRX - GHRS
31%
Poorly correlated
-13.53%
ORMP - GHRS
31%
Poorly correlated
-4.31%
CYTK - GHRS
30%
Poorly correlated
-6.76%
More